We are live on ! Find out more
Polen Capital Management

Polen Capital Management Portfolio holdings

AUM $14.5B
1-Year Est. Return 5.7%
This Fund
S&P 500
This Quarter Est. Return
+0.22%
1 Year Est. Return
+5.7%
3 Year Est. Return
+58.11%
5 Year Est. Return
+55.45%
10 Year Est. Return
+413.15%
AUM
$9.09B
AUM Growth
+$695M
Cap. Flow
+$755M
Cap. Flow %
8.3%
Top 10 Hldgs %
60.53%
Holding
27
New
Increased
24
Reduced
2
Closed
1

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$337M
2
BKNG icon
Booking.com
BKNG
+$73.8M
3
BIDU icon
Baidu
BIDU
+$913K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 25.91%
2 Technology 25.11%
3 Communication Services 17.44%
4 Healthcare 14.03%
5 Financials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIDU icon
26
Baidu
BIDU
$38.3B
-5,013
Closed -$913K

Similar funds

Polen Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Polen Capital Management held 27 positions worth $9.09B, up 8.3% from $8.39B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Polen Capital Management deployed $755M of net new capital in Q4 2016, adding to 24 existing holdings.

By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, down from 27% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Apple, an estimated $337M trimmed.

  • Polen Capital Management added most to Regeneron Pharmaceuticals in Q4 2016, an estimated $201M increase.
  • Polen Capital Management's biggest Q4 2016 reduction was Apple, cutting an estimated $337M.
  • Polen Capital Management fully exited Baidu in Q4 2016, selling an estimated $913K.
  • Polen Capital Management's ten largest holdings make up 61% of its $9.09B portfolio in Q4 2016.
  • Polen Capital Management opened 0 new positions and closed 1 in Q4 2016.
  • Polen Capital Management's portfolio value rose 8.3% quarter-over-quarter to $9.09B.

Based on Polen Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.